World Journal of Hepatology is published by Baishideng Publishing Group (BPG). Choosing BPG’s series of journals means placing compliance with scientific norms and ethical standards at the forefront.

World Journal of Hepatology is aimed to share medical progress, promote medical advances, and improve management of various liver diseases by publishing innovative medical research articles in hepatology. The journal is an international, peer-reviewed, open-access academic journal dedicated to publishing high-quality of original research articles, meta-analysis, review, minireview, guidelines, corresponding, and case report in the field of hepatology, including basic, translational, and clinical studies. The journal focuses on, but is not limited to, the following areas: Basic hepatology research, such as liver development, physiology and regeneration; acute and acute on chronic liver failure; metabolic liver diseases, such as metabolic-associated steatotic liver disease (MASLD), alcoholic liver disease, and drug-induced liver injury; infectious liver diseases, such as viral hepatitis A, B, C, D, and E; autoimmune liver diseases, such as autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis; genetic liver diseases, such as Wilson disease and hemochromatosis; liver tumor, such as hepatocellular carcinoma and cholangiocarcinoma; and liver complications caused by various liver diseases, such as liver fibrosis, cirrhosis and its complication, chronic cholestatic liver disease, and liver transplantation; and other liver diseases such as gut microbiota and liver disease, imaging and drug targeting, and hepatobiliary surgery. The approach of hepatology research can be from laboratory, medicine, surgery, pathology and imaging, novel therapy and intervention, to clinical trials and artificial intelligence. All submissions undergo a rigorous and transparent peer-review process by at least two independent reviewers. Manuscripts are evaluated based on scientific rigor, originality, clinical relevance, and reproducibility, with particular attention to methodological robustness and data integrity. Constructive and timely feedback is provided to ensure the highest standards of scholarly communication. The journal adheres to the highest standards of publication ethics and editorial integrity, in accordance with the guidelines of the Committee on Publication Ethics, the International Committee of Medical Journal Editors, and the World Association of Medical Editors. To advance scientific discovery, promote evidence-based clinical practice, and foster innovation in hepatology, ultimately improving global health outcomes. We invite researchers, clinicians, and multidisciplinary experts worldwide to submit high-quality manuscripts and contribute to shaping the future of hepatic science. Submit an Article>>  

The 2026 edition of Journal Citation Reports® cites the 2025 journal impact factor (JIF) for WJH as 3.4; JIF without journal self cites: 3.2; 5-year JIF: 3.3; JIF Rank: 55/153 in gastroenterology and hepatology; JIF Quartile: Q2; and 5-year JIF Quartile: Q2.

The WJH’s CiteScore for 2025 is 3.9 and Scopus CiteScore rank 2025: Hepatology is 42/88. 

• Ke-Qin Hu, MD, Professor, (E-mail: kqhu@uci.edu) Division of Gastroenterology and Hepatology, University of California Irvine, School of Medicine, Orange, CA 92617, United States
• Joseph K Lim, MD, Professor, (E-mail: joseph.lim@yale.edu) Yale Viral Hepatitis Program, Yale University School of Medicine, New Haven, CT 06520, United States
• Nikolaos T Pyrsopoulos, MD, PhD, Professor, FACP, FACG, AGAF, FAASLD, FRCP, Director, (E-mail: nikolaos.pyrsopoulos@nyulangone.org) Liver Disease in New Jersey, NYU Grossman School of Medicine, NYU Langone Transplant Institutes, New York, NY 10016, United States